Home / VS : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does VS make money? Does VS have pricing power? What's the Earnings Whisper? Will VS profit more as the business scales? What is VS's management track record? Is VS's current price justified?

Versus Systems Inc.

$1.1 -$0.15 (-12.00%)

NASDAQ · 15 Sep 2026 16:08 UTC

Previous Close

$1.03

Day Range

$1.06$1.21

Year Range

$0.75$2.47

Market Cap

5.39M

AVG Volume

37.48K

Trailing/Forward PE

-2.3/-

PEG ratio

0.17

Dividend Yield

Next Earnings Date

2026-11-17

Primary Exchange

NASDAQ

Revenue (USD) · TTM

VS Revenue (USD) · TTM by quarter
Period	Revenue (USD) · TTM
26 Q2	1.51M
26 Q1	2M
25 Q4	2.18M
25 Q3	2.18M
25 Q2	2.18M
25 Q1	230.17K
24 Q4	57.3K
24 Q3	91.52K
24 Q2	110.6K
24 Q1	139.7K

Net Income (USD) · TTM

VS Net Income (USD) · TTM by quarter
Period	Net Income (USD) · TTM
26 Q2	-1.92M
26 Q1	-1.72M
25 Q4	-2M
25 Q3	-1.55M
25 Q2	-1.36M
25 Q1	-3.38M
24 Q4	-3.74M
24 Q3	-8.53M
24 Q2	-9.51M
24 Q1	-10.48M

Operating Income (USD) · TTM

VS Operating Income (USD) · TTM by quarter
Period	Operating Income (USD) · TTM
26 Q2	-2.45M
26 Q1	-2.1M
25 Q4	-2.46M
25 Q3	-2.3M
25 Q2	-1.77M
25 Q1	-4.21M
24 Q4	-4.54M
24 Q3	-8.81M
24 Q2	-10.17M
24 Q1	-10.98M

EBITDA (USD) · TTM

VS EBITDA (USD) · TTM by quarter
Period	EBITDA (USD) · TTM
26 Q2	-2.45M
26 Q1	-2.11M
25 Q4	-2.46M
25 Q3	-2.3M
25 Q2	-1.77M
25 Q1	-3.29M
24 Q4	-3.62M
24 Q3	-3.64M
24 Q2	-4.2M
24 Q1	-5.21M

Cash Flows (USD) · TTM

VS Cash Flows (USD) · TTM by quarter
Period	Cash Flows (USD) · TTM
26 Q2	-1.18M
26 Q1	-1.6M
25 Q4	-2.38M
25 Q3	-2.22M
25 Q2	-2.73M
25 Q1	-3.82M
24 Q4	-4.93M
24 Q3	-5.38M
24 Q2	-5.75M
24 Q1	-5.04M

EPS (USD) · TTM

VS EPS (USD) · TTM by quarter
Period	EPS (USD) · TTM
26 Q2	-0.46
26 Q1	-0.42
25 Q4	-0.48
25 Q3	-0.38
25 Q2	-0.45
25 Q1	-1.13
24 Q4	-1.46
24 Q3	-4.59
24 Q2	-6.66
24 Q1	-9.17

Expenses (USD) · TTM

VS Expenses (USD) · TTM by quarter
Period	Expenses (USD) · TTM
26 Q2	3.97M
26 Q1	4.11M
25 Q4	4.64M
25 Q3	4.16M
25 Q2	3.94M
25 Q1	4.42M
24 Q4	4.56M
24 Q3	5.92M
24 Q2	6.92M
24 Q1	7.75M

Shares Outstanding · TTM

VS Shares Outstanding · TTM by quarter
Period	Shares Outstanding · TTM
26 Q2	-42.95K
26 Q1	-42.95K
25 Q4	-21.48K
25 Q3	0
25 Q2	0
25 Q1	0
24 Q4	0
24 Q3	298.07K
24 Q2	298.07K
24 Q1	298.07K

Employee Count

VS Employee Count by quarter
Period	Employee Count
2025	5
2024	16
2023	8
2022	18

Free Cash Flow Yield

VS Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-23.05%
Sep 26	-21.01%
Sep 26	-19.79%
Aug 26	-18.85%
Aug 26	-18.55%
Aug 26	-16.84%
Aug 26	-24.9%
Jul 26	-26.1%
Jul 26	-23.47%
Jul 26	-21.18%
Jul 26	-21.89%
Jul 26	-24.71%
Jun 26	-26.1%
Jun 26	-26.31%
Jun 26	-23.47%
Jun 26	-22.04%
May 26	-22.04%
May 26	-30.49%
May 26	-28.12%
May 26	-39.87%
May 26	-36.3%
Apr 26	-41.94%
Apr 26	-40.2%
Apr 26	-41.24%
Apr 26	-40.87%
Mar 26	-38.44%
Mar 26	-41.24%
Mar 26	-42.39%
Mar 26	-49.83%
Feb 26	-54.26%
Feb 26	-53.18%
Feb 26	-45.71%
Feb 26	-41.62%
Jan 26	-37.49%
Jan 26	-35.72%
Jan 26	-36%
Jan 26	-35.72%
Jan 26	-36.29%
Dec 25	-36%
Dec 25	-35.16%
Dec 25	-35.72%
Dec 25	-34.63%
Nov 25	-30.24%
Nov 25	-30.86%
Nov 25	-31.94%
Nov 25	-32.52%
Oct 25	-28.08%
Oct 25	-26.48%
Oct 25	-27.8%
Oct 25	-26.1%
Oct 25	-26.1%
Sep 25	-27.26%
Sep 25	-28.37%
Sep 25	-26.73%
Sep 25	-28.51%
Aug 25	-28.51%
Aug 25	-29.26%
Aug 25	-24.28%
Aug 25	-34.61%
Aug 25	-35.23%
Jul 25	-32.72%
Jul 25	-28.31%
Jul 25	-30.06%
Jul 25	-31.27%
Jun 25	-35.23%
Jun 25	-32.85%
Jun 25	-36.05%
Jun 25	-34.3%
May 25	-37.26%
May 25	-39.33%
May 25	-39.53%
May 25	-76.34%
May 25	-74.09%
Apr 25	-74.46%
Apr 25	-76.34%
Apr 25	-71.63%
Apr 25	-79.55%
Mar 25	-101.25%
Mar 25	-104.7%
Mar 25	-98.01%
Mar 25	-96.69%
Feb 25	-101.73%
Feb 25	-104.7%
Feb 25	-107.32%
Feb 25	-101.73%
Jan 25	-93.73%
Jan 25	-78.34%
Jan 25	-77.77%
Jan 25	-105.74%
Jan 25	-92.12%
Dec 24	-94.14%
Dec 24	-98.46%
Dec 24	-124.79%
Dec 24	-124.79%
Nov 24	-140.29%
Nov 24	-130.09%
Nov 24	-141.21%
Nov 24	-130.47%
Nov 24	-117.75%
Oct 24	-94.49%

Price to Sales

VS Price to Sales by quarter
Period	Price to Sales
Sep 26	3.38
Sep 26	3.7
Sep 26	3.93
Aug 26	4.13
Aug 26	4.2
Aug 26	4.62
Aug 26	3.21
Jul 26	3.06
Jul 26	3.4
Jul 26	3.77
Jul 26	3.65
Jul 26	3.23
Jun 26	3.06
Jun 26	3.04
Jun 26	3.4
Jun 26	3.62
May 26	3.62
May 26	2.62
May 26	2.84
May 26	2.74
May 26	3.01
Apr 26	2.6
Apr 26	2.72
Apr 26	2.47
Apr 26	2.5
Mar 26	2.65
Mar 26	2.47
Mar 26	2.41
Mar 26	2.05
Feb 26	1.88
Feb 26	1.92
Feb 26	2.23
Feb 26	2.45
Jan 26	2.72
Jan 26	2.86
Jan 26	2.83
Jan 26	2.86
Jan 26	2.81
Dec 25	2.83
Dec 25	2.9
Dec 25	2.86
Dec 25	2.95
Nov 25	3.37
Nov 25	3.31
Nov 25	3.19
Nov 25	3.84
Oct 25	4.45
Oct 25	4.71
Oct 25	4.49
Oct 25	4.78
Oct 25	4.78
Sep 25	4.58
Sep 25	4.4
Sep 25	4.67
Sep 25	4.38
Aug 25	4.38
Aug 25	4.27
Aug 25	5.14
Aug 25	47.92
Aug 25	47.06
Jul 25	50.68
Jul 25	58.56
Jul 25	55.16
Jul 25	53.03
Jun 25	47.06
Jun 25	50.47
Jun 25	46
Jun 25	48.34
May 25	44.51
May 25	42.17
May 25	41.95
May 25	112.77
May 25	116.19
Apr 25	115.62
Apr 25	112.77
Apr 25	120.18
Apr 25	108.22
Mar 25	58.05
Mar 25	56.13
Mar 25	59.97
Mar 25	60.79
Feb 25	57.78
Feb 25	56.13
Feb 25	54.76
Feb 25	57.78
Jan 25	62.71
Jan 25	75.03
Jan 25	75.57
Jan 25	55.59
Jan 25	63.8
Dec 24	62.43
Dec 24	59.69
Dec 24	47.1
Dec 24	47.1
Nov 24	41.89
Nov 24	45.18
Nov 24	41.62
Nov 24	39.88
Nov 24	44.18
Oct 24	55.06

Price to Book

VS Price to Book by quarter
Period	Price to Book
Sep 26	1.44
Sep 26	1.58
Sep 26	1.68
Aug 26	1.76
Aug 26	1.79
Aug 26	1.97
Aug 26	5.35
Jul 26	5.11
Jul 26	5.68
Jul 26	6.29
Jul 26	6.09
Jul 26	5.39
Jun 26	5.11
Jun 26	5.07
Jun 26	5.68
Jun 26	6.05
May 26	6.05
May 26	4.37
May 26	4.74
May 26	3.12
May 26	3.42
Apr 26	2.96
Apr 26	3.09
Apr 26	1.26
Apr 26	1.27
Mar 26	1.35
Mar 26	1.26
Mar 26	1.23
Mar 26	1.04
Feb 26	0.96
Feb 26	0.98
Feb 26	1.14
Feb 26	1.25
Jan 26	1.39
Jan 26	1.46
Jan 26	1.45
Jan 26	1.46
Jan 26	1.43
Dec 25	1.45
Dec 25	1.48
Dec 25	1.46
Dec 25	1.5
Nov 25	1.72
Nov 25	1.69
Nov 25	1.63
Nov 25	2.2
Oct 25	2.55
Oct 25	2.7
Oct 25	2.57
Oct 25	2.74
Oct 25	2.74
Sep 25	2.63
Sep 25	2.52
Sep 25	2.68
Sep 25	2.51
Aug 25	2.51
Aug 25	2.45
Aug 25	2.95
Aug 25	2.81
Aug 25	2.76
Jul 25	2.97
Jul 25	3.44
Jul 25	3.24
Jul 25	3.11
Jun 25	2.76
Jun 25	2.96
Jun 25	2.7
Jun 25	2.84
May 25	2.61
May 25	2.47
May 25	2.46
May 25	1.28
May 25	1.32
Apr 25	1.31
Apr 25	1.28
Apr 25	1.36
Apr 25	1.23
Mar 25	4.37
Mar 25	4.22
Mar 25	4.51
Mar 25	4.58
Feb 25	4.35
Feb 25	4.22
Feb 25	4.12
Feb 25	4.35
Jan 25	4.72
Jan 25	5.65
Jan 25	5.69
Jan 25	4.18
Jan 25	4.8
Dec 24	4.7
Dec 24	4.49
Dec 24	3.54
Dec 24	3.54
Nov 24	3.15
Nov 24	3.4
Nov 24	3.13
Nov 24	2.45
Nov 24	2.72
Oct 24	3.39

No video analysis for this stock yet. Request one from our team.

News: VS

businesswire.com · 23 Jun 2026

VS-7375 Demonstrates Clinical Activity with a Favorable Safety and Tolerability Profile in TARGET-D 101 Phase 1/2 Clinical Trial in Patients with Advanced KRAS G12D-Mutated Solid Tumors

BOSTON--(BUSINESS WIRE)---- $VSTM #CRC--VS-7375 (investigational KRAS G12D ON/OFF inhibitor) demonstrates clinical activity with a favorable safety profile in TARGET-D 101 clinical trial.

AI Analysis

Versus Systems Inc.

Video analysis: VS

News: VS

VS-7375 Demonstrates Clinical Activity with a Favorable Safety and Tolerability Profile in TARGET-D 101 Phase 1/2 Clinical Trial in Patients with Advanced KRAS G12D-Mutated Solid Tumors

Similar companies